Publications

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.

Ibarz-Pavón, AB; Maclennan, J; Andrews, NJ; Gray, SJ; Urwin, R; Clarke, SC; Walker, AM; Evans, MR; Kroll, JS; Neal, KR; Ala'aldeen, D; Crook, DW; Cann, K; Harrison, S; Cunningham, R; Baxter, D; Kaczmarski, E; McCarthy, ND; Jolley, KA; Cameron, JC; STUART, JM; Maiden, MC J;

2011

The Journal of infectious diseases, (2011).204 7 10.1093/infdis/jir466.

Control of equine influenza: scenario testing using a realistic metapopulation model of spread.

BAGUELIN, M; Newton, JR; Demiris, N; Daly, J; Mumford, JA; Wood, JL N;

2010

Journal of the Royal Society, Interface / the Royal Society, (2010).7 42 10.1098/rsif.2009.0030.

Natural immunization against malaria: causal prophylaxis with antibiotics.

Friesen, J; Silvie, O; Putrianti, ED; HAFALLA, JC R; Matuschewski, K; Borrmann, S;

2010

Science translational medicine, (2010).2 40 10.1126/scitranslmed.3001058.

The India HPV-vaccine suspension.

LARSON, HJ; Brocard, P; Garnett, G;

2010

Lancet, (2010).376 9741 10.1016/S0140-6736(10)60881-1.

Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva.

Clements, MF; Gidwani, K; Kumar, R; Hostomska, J; Dinesh, DS; Kumar, V; Das, P; Müller, I; Hamilton, G; Volfova, V; Boelaert, M; Das, M; Rijal, S; Picado, A; Volf, P; Sundar, S; Davies, CR; ROGERS, ME;

2010

The American journal of tropical medicine and hygiene, (2010).82 5 10.4269/ajtmh.2010.09-0336.

Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis.

Ryckman, KK; FIELDING, K; Hill, AV; Mendy, M; Rayco-Solon, P; Sirugo, G; Van der Sande, MA; Waight, P; Whittle, HC; Hall, AJ; Williams, SM; HENNIG, BJ;

2010

PloS one, (2010).5 8 10.1371/journal.pone.0012273.

Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable?.

Moïsi, JC; Kabuka, J; Mitingi, D; Levine, OS; SCOTT, JA G;

2010

Vaccine, (2010).28 35 10.1016/j.vaccine.2010.06.011.

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.

Russell, FM; Licciardi, PV; Balloch, A; Biaukula, V; Tikoduadua, L; Carapetis, JR; Nelson, J; Jenney, AW J; Waqatakirewa, L; Colquhoun, S; Cheung, YB; Tang, ML K; MULHOLLAND, EK;

2010

Vaccine, (2010).28 18 10.1016/j.vaccine.2010.02.065.

Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review.

O'Loughlin, RE; EDMOND, K; MANGTANI, P; COHEN, AL; Shetty, S; Hajjeh, R; MULHOLLAND, K;

2010

Vaccine, (2010).28 38 10.1016/j.vaccine.2010.06.107.

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.

Melegaro, A; Choi, YH; George, R; EDMUNDS, WJ; MILLER, E; Gay, NJ;

2010

BMC infectious diseases, (2010).10 1 10.1186/1471-2334-10-90.